Filed: 2/13/2025ACC: 0000904454-25-000119
📋 What this filing means
FINEPOINT CAPITAL LP filed this quarterly 13F‑HR report disclosing 26 equity positions with a total reported market value of $1.64B. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
26
Positions
$1.64B
Total AUM (reported)
42.62M
Total Shares
Allocation by class
TR UNIT$442.49M27.0%
COM NEW$423.56M25.9%
RUSSELL 2000 ETF$328.13M20.0%
COM SER C$150.69M9.2%
COM$127.00M7.8%
SPONSORED ADR$58.00M3.5%
COM LBTY LIV S C$55.32M3.4%
Portfolio Concentration
Top 3$1.17B71.3%
4–10$346.39M21.2%
11–25$124.03M7.6%
Rest$14.4K0.0%
Top 3 weight
71.3%
Top 10 weight
92.4%
Voting Authority Distribution
Total shares with voting rights: 42.62M
Sole
Full voting authority
42.62M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole26
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings26
Rows:
SPDR S&P 500 ETF TR
SOLEShares755K
TypeSH
Market value$442.49M
27.02%
Sole
755K
Shared
0.00
None
0.00
QXO INC
SOLEShares24.93M
TypeSH
Market value$396.45M
24.21%
Sole
24.93M
Shared
0.00
None
0.00
ISHARES TR
SOLEShares1.49M
TypeSH
Market value$328.13M
20.04%
Sole
1.49M
Shared
0.00
None
0.00
Liberty Broadband Corp
SOLEShares2.02M
TypeSH
Market value$150.69M
9.20%
Sole
2.02M
Shared
0.00
None
0.00
LIBERTY MEDIA CORP DEL
SOLEShares812.79K
TypeSH
Market value$55.32M
3.38%
Sole
812.79K
Shared
0.00
None
0.00
Argenx SE
SOLEShares52.93K
TypeSH
Market value$32.55M
1.99%
Sole
52.93K
Shared
0.00
None
0.00
REVOLUTION MEDICINES INC
SOLEShares710.26K
TypeSH
Market value$31.07M
1.90%
Sole
710.26K
Shared
0.00
None
0.00
SPRINGWORKS THERAPEUTICS INC
SOLEShares748.75K
TypeSH
Market value$27.05M
1.65%
Sole
748.75K
Shared
0.00
None
0.00
ASCENDIS PHARMA A/S
SOLEShares184.87K
TypeSH
Market value$25.45M
1.55%
Sole
184.87K
Shared
0.00
None
0.00
MoonLake Immunotherapeutics
SOLEShares447.94K
TypeSH
Market value$24.26M
1.48%
Sole
447.94K
Shared
0.00
None
0.00
SAREPTA THERAPEUTICS INC
SOLEShares161.94K
TypeSH
Market value$19.69M
1.20%
Sole
161.94K
Shared
0.00
None
0.00
GALAPAGOS NV
SOLEShares674.76K
TypeSH
Market value$18.56M
1.13%
Sole
674.76K
Shared
0.00
None
0.00
XENCOR INC
SOLEShares660K
TypeSH
Market value$15.17M
0.93%
Sole
660K
Shared
0.00
None
0.00
CYTOKINETICS INC
SOLEShares318.45K
TypeSH
Market value$14.98M
0.91%
Sole
318.45K
Shared
0.00
None
0.00
ARVINAS INC
SOLEShares713.78K
TypeSH
Market value$13.68M
0.84%
Sole
713.78K
Shared
0.00
None
0.00
AVIDITY BIOSCIENCES INC
SOLEShares391.30K
TypeSH
Market value$11.38M
0.69%
Sole
391.30K
Shared
0.00
None
0.00
PROTHENA CORP PLC
SOLEShares657.07K
TypeSH
Market value$9.10M
0.56%
Sole
657.07K
Shared
0.00
None
0.00
RELAY THERAPEUTICS INC
SOLEShares2.18M
TypeSH
Market value$8.96M
0.55%
Sole
2.18M
Shared
0.00
None
0.00
EYEPOINT PHARMACEUTICALS INC
SOLEShares1.11M
TypeSH
Market value$8.28M
0.51%
Sole
1.11M
Shared
0.00
None
0.00
SOLID BIOSCIENCES INC
SOLEShares961.25K
TypeSH
Market value$3.85M
0.23%
Sole
961.25K
Shared
0.00
None
0.00
ALEANNA INC
SOLEShares27.72K
TypeSH
Market value$196.8K
0.01%
Sole
27.72K
Shared
0.00
None
0.00
ALEANNA INC
SOLEShares490K
TypeSH
Market value$68.6K
<0.01%
Sole
490K
Shared
0.00
None
0.00
MONEYHERO LIMITED
SOLEShares895K
TypeSH
Market value$49.4K
<0.01%
Sole
895K
Shared
0.00
None
0.00
LAKESHORE BIOPHARMA CO LTD
SOLEShares490K
TypeSH
Market value$48.5K
<0.01%
Sole
490K
Shared
0.00
None
0.00
Marblegate Acquisition Corp
SOLEShares735K
TypeSH
Market value$25.7K
<0.01%
Sole
735K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
SPDR S&P 500 ETF TRSOLE | TR UNIT | 755K | SH | $442.49M 27.02% | 755K | 0.00 | 0.00 |
QXO INCSOLE | COM NEW | 24.93M | SH | $396.45M 24.21% | 24.93M | 0.00 | 0.00 |
ISHARES TRSOLE | RUSSELL 2000 ETF | 1.49M | SH | $328.13M 20.04% | 1.49M | 0.00 | 0.00 |
Liberty Broadband CorpSOLE | COM SER C | 2.02M | SH | $150.69M 9.20% | 2.02M | 0.00 | 0.00 |
LIBERTY MEDIA CORP DELSOLE | COM LBTY LIV S C | 812.79K | SH | $55.32M 3.38% | 812.79K | 0.00 | 0.00 |
Argenx SESOLE | SPONSORED ADR | 52.93K | SH | $32.55M 1.99% | 52.93K | 0.00 | 0.00 |
REVOLUTION MEDICINES INCSOLE | COM | 710.26K | SH | $31.07M 1.90% | 710.26K | 0.00 | 0.00 |
SPRINGWORKS THERAPEUTICS INCSOLE | COM | 748.75K | SH | $27.05M 1.65% | 748.75K | 0.00 | 0.00 |
ASCENDIS PHARMA A/SSOLE | SPONSORED ADR | 184.87K | SH | $25.45M 1.55% | 184.87K | 0.00 | 0.00 |
MoonLake ImmunotherapeuticsSOLE | CLASS A ORD | 447.94K | SH | $24.26M 1.48% | 447.94K | 0.00 | 0.00 |
SAREPTA THERAPEUTICS INCSOLE | COM | 161.94K | SH | $19.69M 1.20% | 161.94K | 0.00 | 0.00 |
GALAPAGOS NVSOLE | SPON ADR | 674.76K | SH | $18.56M 1.13% | 674.76K | 0.00 | 0.00 |
XENCOR INCSOLE | COM | 660K | SH | $15.17M 0.93% | 660K | 0.00 | 0.00 |
CYTOKINETICS INCSOLE | COM NEW | 318.45K | SH | $14.98M 0.91% | 318.45K | 0.00 | 0.00 |
ARVINAS INCSOLE | COM | 713.78K | SH | $13.68M 0.84% | 713.78K | 0.00 | 0.00 |
AVIDITY BIOSCIENCES INCSOLE | COM | 391.30K | SH | $11.38M 0.69% | 391.30K | 0.00 | 0.00 |
PROTHENA CORP PLCSOLE | SHS | 657.07K | SH | $9.10M 0.56% | 657.07K | 0.00 | 0.00 |
RELAY THERAPEUTICS INCSOLE | COM | 2.18M | SH | $8.96M 0.55% | 2.18M | 0.00 | 0.00 |
EYEPOINT PHARMACEUTICALS INCSOLE | COM NEW | 1.11M | SH | $8.28M 0.51% | 1.11M | 0.00 | 0.00 |
SOLID BIOSCIENCES INCSOLE | COM NEW | 961.25K | SH | $3.85M 0.23% | 961.25K | 0.00 | 0.00 |
ALEANNA INCSOLE | COM CL A | 27.72K | SH | $196.8K 0.01% | 27.72K | 0.00 | 0.00 |
ALEANNA INCSOLE | *W EXP 12/13/202 | 490K | SH | $68.6K <0.01% | 490K | 0.00 | 0.00 |
MONEYHERO LIMITEDSOLE | *W EXP 09/13/202 | 895K | SH | $49.4K <0.01% | 895K | 0.00 | 0.00 |
LAKESHORE BIOPHARMA CO LTDSOLE | *W EXP 03/15/202 | 490K | SH | $48.5K <0.01% | 490K | 0.00 | 0.00 |
Marblegate Acquisition CorpSOLE | *W EXP 08/31/202 | 735K | SH | $25.7K <0.01% | 735K | 0.00 | 0.00 |
Page 1 of 2